{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:37:55Z","timestamp":1789637875854,"version":"4.0.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11154-019-09520-0","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:48:19Z","timestamp":1571831299000},"page":"353-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Calcium citrate: from biochemistry and physiology to clinical applications"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-4926","authenticated-orcid":false,"given":"Andrea","family":"Palermo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda Mihaela","family":"Naciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Tabacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Manfrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Trimboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Falchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"Suppl 1","key":"9520_CR1","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2215\/CJN.05910809","volume":"5","author":"M Peacock","year":"2010","unstructured":"Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S23\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9520_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians Need to know. J Clin Endocrinol Metab. 2011;96:53\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"9520_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11154-011-9197-x","volume":"13","author":"S Christakos","year":"2012","unstructured":"Christakos S. Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption. Rev Endocr Metab Disord. 2012;13:39\u201344.","journal-title":"Rev Endocr Metab Disord"},{"key":"9520_CR4","doi-asserted-by":"crossref","unstructured":"Vautour L, Goltzman D. Regulation of Calcium Homeostasis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism [Internet]. John Wiley & Sons, Ltd; 2018 [cited 2019 Jun 20]. p. 163\u201372. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781119266594.ch22","DOI":"10.1002\/9781119266594.ch22"},{"key":"9520_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/newbio241163a0","volume":"241","author":"DR Fraser","year":"1973","unstructured":"Fraser DR, Kodicek E. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol. 1973;241:163\u20136.","journal-title":"Nat New Biol"},{"key":"9520_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11154-017-9421-4","volume":"18","author":"MR Portillo","year":"2017","unstructured":"Portillo MR, Rodr\u00edguez-Ortiz ME. Secondary Hyperparthyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies. Rev Endocr Metab Disord. 2017;18:79\u201395.","journal-title":"Rev Endocr Metab Disord"},{"key":"9520_CR7","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2147\/CIA.S157523","volume":"13","author":"K Li","year":"2018","unstructured":"Li K, Wang X-F, Li D-Y, Chen Y-C, Zhao L-J, Liu X-G, et al. The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health. Clin Interv Aging. 2018;13:2443\u201352.","journal-title":"Clin Interv Aging"},{"key":"9520_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ajcn\/86.4.1054","volume":"86","author":"CD Hunt","year":"2007","unstructured":"Hunt CD, Johnson LK. Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies. Am J Clin Nutr. 2007;86:1054\u201363.","journal-title":"Am J Clin Nutr"},{"key":"9520_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2486\/indhealth.2014-0225","volume":"54","author":"Y-M Tang","year":"2016","unstructured":"Tang Y-M, Wang D-G, Li J, Li X-H, Wang Q, Liu N, et al. Relationships between micronutrient losses in sweat and blood pressure among heat-exposed steelworkers. Ind Health. 2016;54:215\u201323.","journal-title":"Ind Health"},{"key":"9520_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2011.05.038","volume":"347","author":"S Christakos","year":"2011","unstructured":"Christakos S, Dhawan P, Porta A, Mady LJ, Seth T. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347:25\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"9520_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/35067088","volume":"2","author":"S Tsukita","year":"2001","unstructured":"Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9520_CR12","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1091\/mbc.e07-09-0973","volume":"19","author":"H Fujita","year":"2008","unstructured":"Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, et al. Tight junction proteins Claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. MBoC. 2008;19:1912\u201321.","journal-title":"MBoC."},{"key":"9520_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jcb.10330","volume":"88","author":"F Bronner","year":"2003","unstructured":"Bronner F. Mechanisms of intestinal calcium absorption. J Cell Biochem. 2003;88:387\u201393.","journal-title":"J Cell Biochem"},{"key":"9520_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/joim.12394","volume":"278","author":"IR Reid","year":"2015","unstructured":"Reid IR, Bristow SM, Bolland MJ. Calcium supplements: benefits and risks. J Intern Med. 2015;278:354\u201368.","journal-title":"J Intern Med"},{"key":"9520_CR15","first-page":"15","volume":"8","author":"K Shankar","year":"2018","unstructured":"Shankar K, M S, Raizada P, Jain RA. Randomized open-label clinical study comparing the efficacy, safety, and bioavailability of calcium Lysinate with calcium carbonate and calcium citrate malate in osteopenia patients. J Orthop Case Rep. 2018;8:15\u20139.","journal-title":"J Orthop Case Rep"},{"key":"9520_CR16","doi-asserted-by":"crossref","unstructured":"van der Velde RY, Brouwers JRBJ, Geusens PP, Lems WF, van den Bergh JPW. Calcium and vitamin D supplementation: state of the art for daily practice. Food Nutr Res. 2014;58.","DOI":"10.3402\/fnr.v58.21796"},{"key":"9520_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF03256927","volume":"31","author":"JM Quesada G\u00f3mez","year":"2011","unstructured":"Quesada G\u00f3mez JM, Blanch Rubi\u00f3 J, D\u00edaz Curiel M, D\u00edez PA. Calcium citrate and vitamin D in the treatment of osteoporosis. Clin Drug Investig. 2011;31:285\u201398.","journal-title":"Clin Drug Investig"},{"key":"9520_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/ajcn\/46.4.699","volume":"46","author":"RJ Wood","year":"1987","unstructured":"Wood RJ, Gerhardt A, Rosenberg IH. Effects of glucose and glucose polymers on calcium absorption in healthy subjects. Am J Clin Nutr. 1987;46:699\u2013701.","journal-title":"Am J Clin Nutr"},{"key":"9520_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0115426507022003286","volume":"22","author":"DA Straub","year":"2007","unstructured":"Straub DA. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract. 2007;22:286\u201396.","journal-title":"Nutr Clin Pract"},{"key":"9520_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00045391-199911000-00005","volume":"6","author":"K Sakhaee","year":"1999","unstructured":"Sakhaee K, Bhuket T, Adams-Huet B, Rao DS. Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther. 1999;6:313\u201321.","journal-title":"Am J Ther"},{"key":"9520_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ki.1990.265","volume":"38","author":"LL Hamm","year":"1990","unstructured":"Hamm LL. Renal handling of citrate. Kidney Int. 1990;38:728\u201335.","journal-title":"Kidney Int"},{"key":"9520_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1172\/JCI104306","volume":"40","author":"M Walser","year":"1961","unstructured":"Walser M. Ion association. VI. Interactions between calcium, magnesium, inorganic phosphate, citrate and protein in normal human plasma. J Clin Invest. 1961;40:723\u201330.","journal-title":"J Clin Invest"},{"key":"9520_CR23","unstructured":"Walser M. Divalent Cations: Physiochemical State in Glomerular Filtrate and Urine and Renal Excretion. In Handbook of Physiology. American Physiology Society; 1973."},{"key":"9520_CR24","doi-asserted-by":"publisher","first-page":"s1084","DOI":"10.2741\/1119","volume":"8","author":"R Caudarella","year":"2003","unstructured":"Caudarella R, Vescini F, Buffa A, Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front Biosci. 2003;8:s1084\u2013106.","journal-title":"Front Biosci"},{"key":"9520_CR25","first-page":"F223","volume":"244","author":"DP Simpson","year":"1983","unstructured":"Simpson DP. Citrate excretion: a window on renal metabolism. Am J Phys. 1983;244:F223\u201334.","journal-title":"Am J Phys"},{"key":"9520_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JND-140021","volume":"1","author":"A Chaouch","year":"2014","unstructured":"Chaouch A, Porcelli V, Cox D, Edvardson S, Scarcia P, De Grassi A, et al. Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission. J Neuromuscul Dis. 2014;1:75\u201390.","journal-title":"J Neuromuscul Dis"},{"key":"9520_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajhg.2013.03.009","volume":"92","author":"B Nota","year":"2013","unstructured":"Nota B, Struys EA, Pop A, Jansen EE, Fernandez Ojeda MR, Kanhai WA, et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet. 2013;92:627\u201331.","journal-title":"Am J Hum Genet"},{"key":"9520_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.18632\/oncotarget.714","volume":"3","author":"O Catalina-Rodriguez","year":"2012","unstructured":"Catalina-Rodriguez O, Kolukula VK, Tomita Y, Preet A, Palmieri F, Wellstein A, et al. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget. 2012;3:1220\u201335.","journal-title":"Oncotarget."},{"key":"9520_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/01.mco.0000241661.15514.fb","volume":"9","author":"J Chesney","year":"2006","unstructured":"Chesney J. 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care. 2006;9:535\u20139.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"9520_CR30","doi-asserted-by":"publisher","first-page":"30409","DOI":"10.1074\/jbc.R200006200","volume":"277","author":"OE Owen","year":"2002","unstructured":"Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem. 2002;277:30409\u201312.","journal-title":"J Biol Chem"},{"key":"9520_CR31","first-page":"23","volume":"2015","author":"F Damiano","year":"1849","unstructured":"Damiano F, Tocci R, Gnoni GV, Siculella L. Expression of citrate carrier gene is activated by ER stress effectors XBP1 and ATF6\u03b1, binding to an UPRE in its promoter. Biochim Biophys Acta. 1849;2015:23\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"9520_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2008.08.015","volume":"376","author":"V Iacobazzi","year":"2008","unstructured":"Iacobazzi V, Infantino V, Palmieri F. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. Biochem Biophys Res Commun. 2008;376:15\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"9520_CR33","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1093\/hmg\/ddp370","volume":"18","author":"P Morciano","year":"2009","unstructured":"Morciano P, Carrisi C, Capobianco L, Mannini L, Burgio G, Cestra G, et al. A conserved role for the mitochondrial citrate transporter sea\/SLC25A1 in the maintenance of chromosome integrity. Hum Mol Genet. 2009;18:4180\u20138.","journal-title":"Hum Mol Genet"},{"key":"9520_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1042\/bj0351011","volume":"35","author":"F Dickens","year":"1941","unstructured":"Dickens F. The citric acid content of animal tissues, with reference to its occurrence in bone and tumour. Biochem J. 1941;35:1011\u201323.","journal-title":"Biochem J"},{"key":"9520_CR35","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","volume":"150","author":"P Barcelo","year":"1993","unstructured":"Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150:1761\u20134.","journal-title":"J Urol"},{"key":"9520_CR36","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","volume":"158","author":"B Ettinger","year":"1997","unstructured":"Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069\u201373.","journal-title":"J Urol"},{"key":"9520_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1464-410X.1994.tb07597.x","volume":"73","author":"J Hofbauer","year":"1994","unstructured":"Hofbauer J, H\u00f6barth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study. Br J Urol. 1994;73:362\u20135.","journal-title":"Br J Urol"},{"key":"9520_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-5347(05)64825-2","volume":"168","author":"CYC Pak","year":"2002","unstructured":"Pak CYC, Peterson RD, Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol. 2002;168:31\u20134.","journal-title":"J Urol"},{"key":"9520_CR39","first-page":"85","volume":"54","author":"LA Martini","year":"2000","unstructured":"Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N, et al. High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol. 2000;54:85\u201393.","journal-title":"Clin Nephrol"},{"key":"9520_CR40","first-page":"31","volume":"9","author":"R Caudarella","year":"1995","unstructured":"Caudarella R, Miniero R, Rizzoli E, Copertari N, Buffa A, Perna C, et al. Urinary citrate excretion in healthy women before and after menopause. Ital J Mineral Electrolyte Metab. 1995;9:31\u20138.","journal-title":"Ital J Mineral Electrolyte Metab"},{"key":"9520_CR41","unstructured":"Fournier A, Ghazali A, Bataille P, Cohen Solal M, Marie A, Brazier M, et al. Bone Involvement in Idiopathic Calcium-Stone Formers in In Kidney Stones: Medical and Surgical Management. Lippincott Williams & Wilkins; 1996."},{"key":"9520_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00590032","volume":"21","author":"PJ Osther","year":"1993","unstructured":"Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg P. Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism. Urol Res. 1993;21:169\u201373.","journal-title":"Urol Res"},{"key":"9520_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0272-6386(12)80635-4","volume":"17","author":"CY Pak","year":"1991","unstructured":"Pak CY. Citrate and renal calculi: new insights and future directions. Am J Kidney Dis. 1991;17:420\u20135.","journal-title":"Am J Kidney Dis"},{"key":"9520_CR44","unstructured":"Caudarella R, Buffa A, Rizzoli E, Bianchini G, Vescini F. Is there a link between low urinary citrate excretion and vertebral fractures in postmenopausal females? Ital J Mineral Electrolyte Metab. 2000;14."},{"key":"9520_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00198-003-1567-0","volume":"15","author":"AM Kenny","year":"2004","unstructured":"Kenny AM, Prestwood KM, Biskup B, Robbins B, Zayas E, Kleppinger A, et al. Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporos Int. 2004;15:290\u20134.","journal-title":"Osteoporos Int"},{"key":"9520_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00223-008-9148-z","volume":"83","author":"SDC Thomas","year":"2008","unstructured":"Thomas SDC, Need AG, Tucker G, Slobodian P, O\u2019Loughlin PD, Nordin BEC. Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women. Calcif Tissue Int. 2008;83:81\u20134.","journal-title":"Calcif Tissue Int"},{"key":"9520_CR47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199009273231305","volume":"323","author":"B Dawson-Hughes","year":"1990","unstructured":"Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990;323:878\u201383.","journal-title":"N Engl J Med"},{"key":"9520_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1359\/jbmr.1998.13.2.168","volume":"13","author":"BL Riggs","year":"1998","unstructured":"Riggs BL, O\u2019Fallon WM, Muhs J, O\u2019Connor MK, Kumar R, Melton LJ. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13:168\u201374.","journal-title":"J Bone Miner Res"},{"key":"9520_CR49","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1177\/009127002762491343","volume":"42","author":"HJ Heller","year":"2002","unstructured":"Heller HJ, Poindexter JR, Adams-Huet B. Effect of estrogen treatment and vitamin D status on differing bioavailabilities of calcium carbonate and calcium citrate. J Clin Pharmacol. 2002;42:1251\u20136.","journal-title":"J Clin Pharmacol"},{"key":"9520_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00310254","volume":"57","author":"S Gonnelli","year":"1995","unstructured":"Gonnelli S, Cepollaro C, Camporeale A, Nardi P, Rossi S, Gennari C. Acute biochemical variations induced by two different calcium salts in healthy perimenopausal women. Calcif Tissue Int. 1995;57:175\u20137.","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 2","key":"9520_CR51","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/BF01623220","volume":"3","author":"JY Reginster","year":"1993","unstructured":"Reginster JY. Calcitonins: newer routes of delivery. Osteoporos Int. 1993;3(Suppl 2):S3\u20136 discussion S6-7.","journal-title":"Osteoporos Int"},{"key":"9520_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3945\/an.116.014258","volume":"8","author":"S Sherf Dagan","year":"2017","unstructured":"Sherf Dagan S, Goldenshluger A, Globus I, Schweiger C, Kessler Y, Kowen Sandbank G, et al. Nutritional recommendations for adult bariatric surgery patients: clinical practice. Adv Nutr. 2017;8:382\u201394.","journal-title":"Adv Nutr"},{"key":"9520_CR53","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s13679-017-0271-x","volume":"6","author":"MA Via","year":"2017","unstructured":"Via MA, Mechanick JI. Nutritional and micronutrient Care of Bariatric Surgery Patients: current evidence update. Curr Obes Rep. 2017;6:286\u201396.","journal-title":"Curr Obes Rep"},{"key":"9520_CR54","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s11695-009-9850-6","volume":"19","author":"P Tondapu","year":"2009","unstructured":"Tondapu P, Provost D, Adams-Huet B, Sims T, Chang C, Sakhaee K. Comparison of the absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass. Obes Surg. 2009;19:1256\u201361.","journal-title":"Obes Surg"},{"key":"9520_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.soard.2011.05.001","volume":"8","author":"K Sakhaee","year":"2012","unstructured":"Sakhaee K, Griffith C, Pak CYC. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis. 2012;8:67\u201372.","journal-title":"Surg Obes Relat Dis"},{"key":"9520_CR56","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1210\/jc.2006-0557","volume":"91","author":"M Shah","year":"2006","unstructured":"Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91:4223\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"9520_CR57","first-page":"751","volume":"237","author":"HJ Sugerman","year":"2003","unstructured":"Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751\u20138.","journal-title":"Ann Surg"},{"key":"9520_CR58","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s11695-017-2932-y","volume":"28","author":"J-H Wei","year":"2018","unstructured":"Wei J-H, Lee W-J, Chong K, Lee Y-C, Chen S-C, Huang P-H, et al. High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures. Obes Surg. 2018;28:798\u2013804.","journal-title":"Obes Surg"},{"issue":"Suppl 1","key":"9520_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1590\/S0102-6720201500S100013","volume":"28","author":"GAP Baretta","year":"2015","unstructured":"Baretta GAP, Cambi MPC, Rodrigues AL, Mendes SA. Secondary hyperparathyroidism after bariatric surgery: treatment is with calcium carbonate or calcium citrate? Arq Bras Cir Dig. 2015;28(Suppl 1):43\u20135.","journal-title":"Arq Bras Cir Dig"},{"key":"9520_CR60","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.juro.2006.09.033","volume":"177","author":"JR Asplin","year":"2007","unstructured":"Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565\u20139.","journal-title":"J Urol"},{"key":"9520_CR61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.soard.2005.07.002","volume":"1","author":"WK Nelson","year":"2005","unstructured":"Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481\u20135.","journal-title":"Surg Obes Relat Dis"},{"key":"9520_CR62","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/jbmr.2467","volume":"30","author":"AL Schafer","year":"2015","unstructured":"Schafer AL, Weaver CM, Black DM, Wheeler AL, Chang H, Szefc GV, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30:1377\u201385.","journal-title":"J Bone Miner Res"},{"key":"9520_CR63","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jsbmb.2016.12.012","volume":"173","author":"AL Schafer","year":"2017","unstructured":"Schafer AL. Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol. 2017;173:202\u201310.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9520_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bonr.2018.02.002","volume":"8","author":"K Corbeels","year":"2018","unstructured":"Corbeels K, Verlinden L, Lannoo M, Simoens C, Matthys C, Verstuyf A, et al. Thin bones: vitamin D and calcium handling after bariatric surgery. Bone Rep. 2018;8:57\u201363.","journal-title":"Bone Rep"},{"key":"9520_CR65","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.soard.2011.11.011","volume":"9","author":"K Sakhaee","year":"2013","unstructured":"Sakhaee K, Pak C. Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9:743\u20138.","journal-title":"Surg Obes Relat Dis"},{"key":"9520_CR66","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cen.13836","volume":"89","author":"L Ring Madsen","year":"2018","unstructured":"Ring Madsen L, Espersen R, Rejnmark L, Richelsen B. Effect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after roux-en-Y gastric bypass. A double-blinded, randomized trial. Clin Endocrinol. 2018;89:734\u201341.","journal-title":"Clin Endocrinol"},{"key":"9520_CR67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.soard.2016.12.018","volume":"13","author":"J Parrott","year":"2017","unstructured":"Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13:727\u201341.","journal-title":"Surg Obes Relat Dis"},{"key":"9520_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM198507113130202","volume":"313","author":"RR Recker","year":"1985","unstructured":"Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985;313:70\u20133.","journal-title":"N Engl J Med"},{"key":"9520_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/17446651.2015.971755","volume":"10","author":"NE Cusano","year":"2015","unstructured":"Cusano NE, Rubin MR, Bilezikian JP. PTH(1-84) replacement therapy for the treatment of hypoparathyroidism. Expert Rev Endocrinol Metab. 2015;10:5\u201313.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"9520_CR70","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/jbmr.3480","volume":"33","author":"RI Gafni","year":"2018","unstructured":"Gafni RI, Langman CB, Guthrie LC, Brillante BA, James R, Yovetich NA, et al. Hypocitraturia is an untoward side effect of synthetic human parathyroid hormone (hPTH) 1-34 therapy in hypoparathyroidism that may increase renal morbidity. J Bone Miner Res. 2018;33:1741\u20137.","journal-title":"J Bone Miner Res"},{"key":"9520_CR71","first-page":"182","volume":"81","author":"R Caudarella","year":"2009","unstructured":"Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl. 2009;81:182\u20137.","journal-title":"Arch Ital Urol Androl"},{"key":"9520_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","volume":"158","author":"HA Fink","year":"2013","unstructured":"Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158:535\u201343.","journal-title":"Ann Intern Med"},{"key":"9520_CR73","doi-asserted-by":"publisher","first-page":"292953","DOI":"10.1155\/2013\/292953","volume":"2013","author":"KP Aggarwal","year":"2013","unstructured":"Aggarwal KP, Narula S, Kakkar M, Tandon C. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int. 2013;2013:292953.","journal-title":"Biomed Res Int"},{"key":"9520_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ki.1990.7","volume":"37","author":"DJ Kok","year":"1990","unstructured":"Kok DJ, Papapoulos SE, Bijvoet OL. Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int. 1990;37:51\u20136.","journal-title":"Kidney Int"},{"key":"9520_CR75","doi-asserted-by":"crossref","unstructured":"Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015;CD010057.","DOI":"10.1002\/14651858.CD010057.pub2"},{"issue":"6","key":"9520_CR76","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/nu9060538","volume":"9","author":"Renata Carnauba","year":"2017","unstructured":"Carnauba RA, Baptistella AB, Paschoal V, H\u00fcbscher GH. Diet-Induced Low-Grade Metabolic Acidosis and Clinical Outcomes: A Review. Nutrients. 2017;9.","journal-title":"Nutrients"},{"key":"9520_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11154-016-9397-5","volume":"18","author":"EO Gosmanova","year":"2017","unstructured":"Gosmanova EO, Gosmanov AR. Osteoporosis in patients with diabetes after kidney transplantation. Rev Endocr Metab Disord. 2017;18:97\u2013106.","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09520-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-019-09520-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09520-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T15:18:02Z","timestamp":1650467882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-019-09520-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9520"],"URL":"https:\/\/doi.org\/10.1007\/s11154-019-09520-0","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"23 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors Anda Mihaela Naciu, Gaia Tabacco, Silvia Manfrini and Pierpaolo Trimboli, declare that they have no conflict of interest. Andrea Palermo, Fabio Vescini and Alberto Falchetti have received research grants from Amgen and Abiogen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}